Role of Molecular Imaging in Oncology
Journal Title: Cancer Studies & Molecular Medicine – Open Journal - Year 2014, Vol 1, Issue 1
Abstract
Molecular Imaging (MI) is an emerging technology for the early detection of disease, staging of the disease, and for monitoring response to therapy. It also offers a non-invasive method to detect in vivo biological functions and processes at a molecular level. The use of MI requires careful selection of targeting molecules which are expressed differentially in diseased vs. healthy cells to interrogate the cell microenvironment. Targeting molecules for MI could consist of small molecules, single amino acid units, low molecular weight peptides, antibodies or antibody fragments. Over the years, a large number of small molecular weight imaging probes have been developed to target different molecular pathways using Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT). The use of high molecular weight probes such as radioactive antibodies (Ab) is also equally attractive. While a major effort is placed on developing radioactive probes for PET and SPECT imaging, an intense effort is being focused on enhancing the utility of other MI modalities such as nuclear Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS), Computed Tomography (CT), optical imaging and ultrasound (US).
Authors and Affiliations
Pradeep K. Garg
Keywords
Related Articles
- EP ID EP552507
- DOI 10.17140/CSMMOJ-1-e001
- Views 111
- Downloads 0
Application of Radionuclides and Antibody-Drug Conjugates to Target Cancer
Radionuclide therapy and antibody-drug conjugates are used to locate and kill cancer cells by the utilisation of monoclonal antibodies. These bio-vectors are able to transport a cytotoxic drug payload and/or radiation in...
Is it Time to Start Using Mitochondrial DNA Copy Number as an Indicator of Health and Diseases?
Clinical biochemistry and pathology have contributed too many assays for diagnosis and prognosis of human health and diseases. Bedside biochemistry has revolutionized modern medicine and the invention of new generation b...
The Emerging Spectrum of Early Life Exposure-Related Inflammation and Epigenetic Therapy
Early life exposure to a variety of insults during sensitive windows of development can reprogram normal physiological responses and alter disease susceptibility later in life. During this process, inflammation triggered...
Rounding Down Chemotherapeutic Agents to the Nearest Vial Size as a Cost Containment Measure
Background: High cancer treatment costs significantly affect health care expenditures. Drug waste reduction of costly drugs can reduce the treatment cost. Methods: A retrospective study conducted at King Abdulaziz Medica...
Immuno-oncology: Is it a new hope for cancer patients?
Cancer is the one of the leading causes of death, whose incidences is increasing day by day due to lack of understanding about its complete mechanism. Therefore, to understand complete mechanism of cancer, researchers st...